Immune Pharmaceuticals, Inc.
(NASDAQ : IMNP)

( )
IMNP After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
0.49%14.4214.2%$227.85m
SHPGShire PLC Sponsored ADR
-0.22%142.840.4%$213.78m
PRGOPerrigo Co. Plc
-1.49%77.436.4%$150.76m
MNKMallinckrodt Plc
0.22%37.2017.7%$117.37m
UTHRUnited Therapeutics Corporation
-0.43%130.7213.9%$87.52m
JAZZJazz Pharmaceuticals Plc
-0.16%146.502.2%$80.04m
ENDPEndo International Plc
-0.48%8.348.9%$70.27m
HZNPHorizon Pharma plc
-1.45%12.937.6%$64.54m
ALRAlere Inc.
-0.35%49.392.7%$63.82m
PRXLPAREXEL International Corporation
-0.08%87.667.9%$62.65m
ICPTIntercept Pharmaceuticals, Inc.
-0.14%106.9422.1%$62.05m
MYOKMyoKardia, Inc.
0.80%44.153.0%$54.03m
MDCOMedicines Company
1.92%36.0922.3%$43.38m
PTLAPortola Pharmaceuticals, Inc.
0.59%56.288.9%$42.36m
ICLRICON Plc
-1.03%106.784.2%$41.60m

Company Profile

Immune Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It engages in the development and commercialization of targeted therapeutics, including mAbs nanotherapeutics and antibody drug conjugates, for the treatment of inflammatory diseases and cancer. The company acquires, develops and commercialises prescription drug products. Immune Pharmaceuticals was founded by Daniel G. Teper and Jean Elie Kadouche in March, 1993 and is headquartered in New York, NY.